Physician profile
Preston Sacks
NPI 1760569420
$1,959.88
in general payments reported to CMS, 2019-2025
11 companies · $229 in 2025
The $229 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $540 · 2020: $121 · 2021: $154 · 2022: $176 · 2023: $367 · 2024: $374 · 2025: $229.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $969.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $969.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $1,200.49 | 2019-2025 | Menopur |
| Emd Serono, INC. | $206.52 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $206.25 | 2019-2020 | |
| Abbvie INC. | $203.05 | 2019-2022 | |
| Vitrolife INC. | $39.66 | 2024 | |
| Organon LLC | $31.04 | 2021-2022 | |
| Avion Pharmaceuticals | $17.20 | 2021 | |
| Alfasigma USA, INC. | $16.41 | 2021 | |
| Coopersurgical, INC. | $14.33 | 2023 | Endosee |
| Hologic Sales and Service, LLC | $12.75 | 2020 | |
| Vertical Pharmaceuticals, LLC | $12.18 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Preston Sacks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.